ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APH Alliance Pharma Plc

39.70
0.20 (0.51%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.51% 39.70 39.50 39.70 39.75 38.10 39.05 1,198,676 16:29:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 167.42M 936k 0.0017 233.53 214.44M

Alliance Pharma PLC Preliminary Results -3-

25/03/2015 7:01am

UK Regulatory


Consolidated Income Statement

 
                                                     Year                   Year 
                                                    ended                  ended 
                                              31 December            31 December 
                                                     2014                   2013 
                                       Note                            Restated* 
                                                 GBP 000s               GBP 000s 
-------------------------------------  ----  ------------  --------------------- 
Revenue                                            43,536                 45,275 
Cost of sales                                    (18,493)               (17,944) 
-------------------------------------  ----  ------------  --------------------- 
Gross profit                                       25,043                 27,331 
-------------------------------------  ----  ------------  --------------------- 
 
Operating expenses 
Administration and marketing expense             (12,510)               (12,917) 
Amortisation of intangible assets                   (488)                  (422) 
Share-based employee remuneration                   (571)                  (632) 
Share of joint venture profits 
 / (losses)                                           319                   (48) 
-------------------------------------  ----  ------------  --------------------- 
                                                 (13,250)               (14,019) 
-------------------------------------  ----  ------------  --------------------- 
 
Operating profit excluding exception 
 item 
                                                   11,793                 13,312 
 Exceptional item: impairment of 
 intangible asset                                   (622)                      - 
-------------------------------------  ----  ------------  --------------------- 
 
Operating profit                                   11,171                 13,312 
 
Finance costs 
Interest payable and similar charges      2       (1,090)                (1,281) 
Interest income                           2            48                     50 
Other finance income / (charges)          2            28                   (72) 
                                                  (1,014)                (1,303) 
-------------------------------------  ----  ------------  --------------------- 
 
Profit on ordinary activities 
 before taxation                                   10,157                 12,009 
Taxation                                  3       (1,772)                (2,425) 
-------------------------------------  ----  ------------  --------------------- 
Profit for the year attributable 
 to equity shareholders                             8,385                  9,584 
-------------------------------------  ----  ------------  --------------------- 
Earnings per share 
Basic (pence)                             5          3.17                   3.82 
Diluted (pence)                           5          3.16                   3.68 
-------------------------------------  ----  ------------  --------------------- 
 

*Restated due to the adoption of IFRS 11, please see note 11.

Consolidated Statement of Comprehensive Income

 
                                          Year ended     Year ended 
                                         31 December    31 December 
                                                2014           2013 
                                            GBP 000s       GBP 000s 
 
 Profit for the period                         8,385          9,584 
 
   Other comprehensive income 
 
   Other items recognised directly 
   in equity 
   Items that may be reclassified 
   to profit or loss 
 Interest rate swaps - cash flow 
  hedge                                        (572)            443 
 Deferred tax on interest rate 
  swaps                                          119           (93) 
 Foreign exchange translation                      7              - 
  differences 
 Share of joint venture OCI                      (8)              - 
 
 Total comprehensive income for 
  the period                                   7,931          9,934 
-------------------------------------  -------------  ------------- 
 
 

Consolidated Statement of Financial Position

 
                                     31 December  31 December  31 December  31 December 
                                            2014         2014         2013         2013 
                                                                 Restated*    Restated* 
                               Note     GBP 000s     GBP 000s     GBP 000s     GBP 000s 
-----------------------------  ----  -----------  -----------  -----------  ----------- 
Assets 
Non-current assets 
Intangible assets                 6       88,875                    87,111 
Property, plant and 
 equipment                                   396                       592 
Joint Venture Investment                   1,271                       533 
Joint Venture Receivable                   1,462                     1,462 
Derivative financial 
 instruments                                   -                       443 
Deferred tax asset                           194                         - 
                                                       92,198                    90,141 
Current assets 
Inventories                                5,914                     5,468 
Trade and other receivables       7        8,322                    10,641 
Cash and cash equivalents        10        1,434                       687 
                                                       15,670                    16,796 
Total assets                                          107,868                   106,937 
-----------------------------  ----  -----------  -----------  -----------  ----------- 
 
Equity 
Ordinary share capital                     2,641                     2,641 
Share premium account                     29,388                    29,380 
Share option reserve                       1,995                     1,424 
Reverse takeover reserve                   (329)                     (329) 
Other reserve                              (103)                       350 
Retained earnings                         37,188                    31,202 
-----------------------------  ----  -----------  -----------  -----------  ----------- 
Total equity                                           70,780                    64,668 
 
Liabilities 
Non-current liabilities 
Long term financial 
 liabilities                              19,235                    20,881 
Deferred tax liability                     6,309                     6,294 
Provisions for other 
 liabilities                                   -                       199 
Derivative financial 
 instruments                                 129                         - 
-----------------------------  ----  -----------  -----------  -----------  ----------- 
                                                       25,673                    27,374 
Current liabilities 
Cash and cash equivalents        10          414                     2,125 
Financial liabilities                      2,895                     2,895 
Corporation tax                              959                     1,154 
Trade and other payables          8        6,920                     8,531 
Provisions for other 
 liabilities                                 227                       190 
                                                       11,415                    14,895 
Total liabilities                                      37,088                    42,269 
 
Total equity and liabilities                          107,868                   106,937 
-----------------------------  ----  -----------  -----------  -----------  ----------- 
 
 

*Restated due to the adoption of IFRS 11, please see note 11

Consolidated Statement of Changes in Equity

 
                             Ordinary      Share      Share     Reverse 
                                share    premium     option    takeover      Other    Retained     Total 
                              capital    account    reserve     reserve    reserve    earnings    equity 
                                                                                                     GBP 
                             GBP 000s   GBP 000s   GBP 000s    GBP 000s   GBP 000s    GBP 000s      000s 
 
 Balance 1 January 
  2014                          2,641     29,380      1,424       (329)        350      31,202    64,668 
--------------------------  ---------  ---------  ---------  ----------  ---------  ----------  -------- 
 
 Issue of shares                    -          8          -           -          -           -         8 
 Dividend paid                      -          -          -           -          -     (2,398)   (2,398) 
 Share options charge               -          -        571           -          -           -       571 
--------------------------  ---------  ---------  ---------  ----------  ---------  ----------  -------- 
 Transactions with 
  owners                            -          8        571           -          -     (2,398)   (1,819) 
--------------------------  ---------  ---------  ---------  ----------  ---------  ----------  -------- 
 Profit for the period              -          -          -           -          -       8,385     8,385 
 Other comprehensive 
  income 
 Interest rate swaps 
  - cash flow hedge                 -          -          -           -      (572)           -     (572) 
 Deferred tax on interest 
  rate swap                         -          -          -           -        119           -       119 
 Foreign exchange 
  translation differences           -          -          -           -          -         (1)       (1) 
--------------------------  ---------  ---------  ---------  ----------  ---------  ----------  -------- 
 Total comprehensive 

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Your Recent History

Delayed Upgrade Clock